96 related articles for article (PubMed ID: 11925887)
1. [Management of intraoperative anticoagulantless CHD with EVAL-dialyzer in four patients on maintenance hemodialysis].
Wake M; Sanagawa Y; Tanaka Y
Masui; 2002 Mar; 51(3):250-4. PubMed ID: 11925887
[TBL] [Abstract][Full Text] [Related]
2. Ethylene-vinyl alcohol copolymer dialyzer membrane reduces protein oxidation in hemodialysis patients.
Matsumoto Y; Mukai M; Arihara K; Saito T; Kumagai H
Ren Fail; 2011; 33(4):382-7. PubMed ID: 21529266
[TBL] [Abstract][Full Text] [Related]
3. Superior outcome of nafamostat mesilate as an anticoagulant in patients undergoing maintenance hemodialysis with intracerebral hemorrhage.
Yang JW; Han BG; Kim BR; Lee YH; Kim YS; Yu JM; Choi SO
Ren Fail; 2009; 31(8):668-75. PubMed ID: 19814633
[TBL] [Abstract][Full Text] [Related]
4. Heparin-free dialysis and ethylene-vinyl-alcohol (EVAL) dialyzer reuse in high-risk bleeding patients.
Leanza H; Rivarola G; Garcia G; Ryan C; Najun Zarazaga CJ
Transplant Proc; 1991 Apr; 23(2):1835. PubMed ID: 2053171
[No Abstract] [Full Text] [Related]
5. Adsorption of Nafamostat Mesilate on AN69ST Membranes: A Single-Center Retrospective and In Vitro Study.
Nakamura Y; Hara S; Hatomoto H; Yamasaki S; Nakano T; Miyazaki M; Matsumoto N; Irie Y; Ishikura H
Ther Apher Dial; 2017 Dec; 21(6):620-627. PubMed ID: 28960755
[TBL] [Abstract][Full Text] [Related]
6. [Heparin-free hemodialysis in chronic patients for temporary management of conditions with a high risk of bleeding].
Stradtmann H; Förster S; Jalinski W
Z Urol Nephrol; 1988 Jul; 81(7):449-53. PubMed ID: 3176720
[TBL] [Abstract][Full Text] [Related]
7. Association between Intra-Circuit Activated Clotting Time and Incidence of Bleeding Complications during Continuous Renal Replacement Therapy using Nafamostat Mesilate: a Retrospective Pilot Observational Study.
Miyatake Y; Makino S; Kubota K; Egi M; Mizobuchi S
Kobe J Med Sci; 2017 Aug; 63(1):E30-E36. PubMed ID: 29434171
[TBL] [Abstract][Full Text] [Related]
8. Role of the dialyzer membrane on the overall phosphate kinetics during hemodialysis.
Katopodis KP; Chala A; Koliousi E; Takouli L; Kalaitzidis R; Theodorou J; Siamopoulos KC
Blood Purif; 2005; 23(5):359-64. PubMed ID: 16088103
[TBL] [Abstract][Full Text] [Related]
9. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
[TBL] [Abstract][Full Text] [Related]
10. Effect of different dialyzer membranes on cutaneous microcirculation during hemodialysis.
Sato M; Morita H; Ema H; Yamaguchi S; Amano I
Clin Nephrol; 2006 Dec; 66(6):426-32. PubMed ID: 17176914
[TBL] [Abstract][Full Text] [Related]
11. [Daily hemodialysis of ultra-short duration with non-traumatic vascular access. Two cases].
Marichal JF; Brignon P; Faller B
Nephrologie; 1990; 11(3):135-6. PubMed ID: 2234268
[TBL] [Abstract][Full Text] [Related]
12. Coagulation cascade activation causes CC chemokine receptor-2 gene expression and mononuclear cell activation in hemodialysis patients.
Pertosa G; Simone S; Soccio M; Marrone D; Gesualdo L; Schena FP; Grandaliano G
J Am Soc Nephrol; 2005 Aug; 16(8):2477-86. PubMed ID: 15976001
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
14. Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry.
Abe M; Hamano T; Wada A; Nakai S; Masakane I;
PLoS One; 2017; 12(9):e0184424. PubMed ID: 28910324
[TBL] [Abstract][Full Text] [Related]
15. Influence of the ionic dialysance monitor on Kt measurement in hemodialysis.
Maduell F; Vera M; Arias M; Serra N; Blasco M; Bergadá E; Fontsere N; Cases A; Campistol JM
Am J Kidney Dis; 2008 Jul; 52(1):85-92. PubMed ID: 18455852
[TBL] [Abstract][Full Text] [Related]
16. [12 or 16 hours of hemodialysis weekly? A Czechoslovak coil dialyzer, 2 x 6 or 2 x 8 hours weekly].
Lisý Z; Tomásek R
Cas Lek Cesk; 1985 Sep; 124(37):1170-4. PubMed ID: 4042131
[No Abstract] [Full Text] [Related]
17. Determinants of prescribed dialysis dose and survival in a cohort of chronic hemodialysis patients.
Iseki K; Tozawa M; Takishita S
Clin Exp Nephrol; 2003 Sep; 7(3):231-7. PubMed ID: 14586720
[TBL] [Abstract][Full Text] [Related]
18. Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances.
Song JH; Park GH; Lee SY; Lee SW; Lee SW; Kim MJ
J Am Soc Nephrol; 2005 Jan; 16(1):237-46. PubMed ID: 15563561
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary function in renal transplant recipients and end-stage renal disease patients undergoing maintenance dialysis.
Karacan O; Tutal E; Colak T; Sezer S; Eyüboğlu FO; Haberal M
Transplant Proc; 2006 Mar; 38(2):396-400. PubMed ID: 16549130
[TBL] [Abstract][Full Text] [Related]
20. [Lobectomy for lung cancer in an elderly man on maintenance hemodialysis].
Shirasawa B; Hanada S; Harada M; Tomozawa N; Hamano K
Kyobu Geka; 2004 Nov; 57(12):1094-8. PubMed ID: 15553022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
